Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PRACTICE OF PHARMACY. | All human laboratory testing is regulated under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). CLIA-waived tests are simple laboratory examinations and procedures that have an insignificant risk of an erroneous result. Common CLIA-waived tests include Influenza, HIV, COVID-19, and lipid-panel tests. Amid COVID-19 pandemic, the need for immediate diagnostic services that are close to home became vital. This bill authorizes pharmacists to order and perform tests authorized by the FDA and CLIA-waived and provide treatment for such health conditions. | us/states/de | Delaware General Assembly | 151 | HB 399 | Delaware HB 399 (151) |
|
enacted |
|
4 | 16 | 3 | 2022-05-03 | 2022-10-03 | openstates | ocd-bill/614f4e60-ae0f-42de-9e2e-a9a0e61e4bd0 | https://legis.delaware.gov/BillDetail?LegislationId=109428 | 2db59daa6dca240f12c542529a65c49ec0b08fa67dfd58a30b14e5b8c176bf1c | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware HB 399 (151) — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PRACTICE OF PHARMACY.
All human laboratory testing is regulated under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). CLIA-waived tests are simple laboratory examinations and procedures that have an insignificant risk of an erroneous result. Common CLIA-waived tests include Influenza, HIV, COVID-19, and lipid-panel tests. Amid COVID-19 pandemic, the need for immediate diagnostic services that are close to home became vital. This bill authorizes pharmacists to order and perform tests authorized by the FDA and CLIA-waived and provide treatment for such health conditions.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
- HA 1 to HB 399 (committee substitute) — source
- HA 2 to HB 399 (committee substitute) — source
- SA 1 to HB 399 (committee substitute) — source
Votes
- SM — 41–0 (pass) · lower
- SM — 39–0 (pass) · lower
- SM — 21–0 (pass) · upper
Sponsors
- Andria L. Bennett — primary (person)
- Kendra Johnson — primary (person)
- Marie Pinkney — primary (person)
- Edward S. Osienski — cosponsor (person)
- Eric Morrison — cosponsor (person)
- Kimberly Williams — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Sherry Dorsey Walker — cosponsor (person)
- Spiros Mantzavinos — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-05-03 Introduced and Assigned to Health & Human Development Committee in House
introduction, referral-committee - 2022-05-11 Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 7 On Its Merits
committee-passage, committee-passage-favorable - 2022-05-17 Amendment HA 1 to HB 399 - Introduced and Placed With Bill
amendment-introduction - 2022-05-19 Amendment HA 2 to HB 399 - Introduced and Placed With Bill
amendment-introduction - 2022-05-19 Amendment HA 1 to HB 399 - Passed In House by Voice Vote
amendment-passage - 2022-05-19 Amendment HA 2 to HB 399 - Passed In House by Voice Vote
amendment-passage - 2022-05-19 Passed By House. Votes: 39 YES 2 ABSENT
passage - 2022-05-19 Assigned to Health & Social Services Committee in Senate
introduction, referral-committee - 2022-06-08 Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 2 On Its Merits
committee-passage, committee-passage-favorable - 2022-06-30 Amendment SA 1 to HB 399 - Introduced and Placed With Bill
amendment-introduction - 2022-06-30 Amendment SA 1 to HB 399 - Passed By Senate. Votes: 21 YES
amendment-passage - 2022-06-30 Laid On Table in Senate
- 2022-07-01 Lifted From Table in Senate
- 2022-07-01 Passed By Senate. Votes: 21 YES
passage - 2022-07-01 Passed By House. Votes: 41 YES
passage - 2022-10-03 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/614f4e60-ae0f-42de-9e2e-a9a0e61e4bd0. Confidence: reported (aggregated from official Delaware legislature records).